←Cardiology & EP
Wide-complex tachycardia & VT
📚
📚 Library › ❤️ Cardiology & EP › Arrhythmias
🚨

Wide-complex tachycardia & VT

Assume VT until proven otherwise. Stable vs unstable, procainamide vs amiodarone, VT storm.

VTWCTprocainamideICDVT storm
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2017 AHA/ACC/HRS VA/SCD guideline · 2022 ESC VA guideline · 2025 AHA ACLS
🧠 Pathophysiology in 60 seconds🔎 Diagnosis🧪 Workup💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Wide + regular + fast = VT until proven otherwise — especially with prior MI or low EF.
  • No pulse → ACLS (defibrillate, CPR, epinephrine, amiodarone).
  • Pulse but unstable → synchronized cardioversion 100 J.
  • Stable monomorphic VT → procainamide (or amiodarone) + prepare to cardiovert.
  • Polymorphic VT: long QT → magnesium (torsades). Normal QT → think ischemia → cath lab.
  • Fix K >4, Mg >2. Never verapamil/diltiazem for WCT.

🧠 Pathophysiology in 60 seconds

⌄
  • Scar re-entry (old MI, cardiomyopathy) → monomorphic VT. Scar = one fixed circuit → same QRS shape every beat.
  • Ischemia, long QT, electrolytes → polymorphic VT / torsades.
  • The ventricle depolarizes muscle-to-muscle, not through the fast His-Purkinje system → wide QRS.
  • Fast rate + loss of AV synchrony → low output → collapse → VF.

🔎 Diagnosis

⌄
Monomorphic VT — wide, regular, ~165/min
Regular wide-complex tachycardia. Clues for VT: AV dissociation, capture or fusion beats, very wide QRS (>160 ms), extreme axis.
Schematic drawing · 25 mm/s · 10 mm/mV · swipe ↔
Points for VT Points for SVT with aberrancy
Prior MI, HF, ICD, age >35 Young, no heart disease, known BBB
AV dissociation, fusion/capture beats Same QRS as baseline BBB
QRS >160 ms, northwest axis Typical RBBB/LBBB pattern
Concordance in precordial leads Terminates with adenosine
💡 Pearl

Hemodynamic stability does not mean it is SVT. Many patients walk in with stable VT.

🧪 Workup

⌄

ECG (compare with old), BMP, Mg, troponin, TTE (EF, scar), drug list (QT, digoxin), ICD interrogation if present, ischemia evaluation (cath or stress), cardiac MRI for new cardiomyopathy (sarcoid, myocarditis).

💊 Management

⌄
  • Procainamide 20–50 mg/min IV until stops, hypotension, QRS widens >50%, or 17 mg/kg. (PROCAMIO: fewer major adverse events than amiodarone.)
  • Amiodarone 150 mg IV over 10 min, repeat as needed → 1 mg/min ×6 h → 0.5 mg/min ×18 h. Best choice in low EF.
  • Lidocaine 1–1.5 mg/kg IV — alternative, especially with ischemia.
  • Sedate and synchronized cardioversion 100 J if drugs fail.
  • Pulse + unstable → sync 100 J, increase as needed.
  • Pulseless VT/VF → defibrillate (unsynchronized), CPR, epinephrine 1 mg q3–5 min, amiodarone 300 mg → 150 mg (or lidocaine).
  • Long QT (torsades) → Mg 2 g IV, stop QT drugs, overdrive pacing / isoproterenol. See QT page.
  • Normal QT → ischemia until proven otherwise → treat as ACS, urgent cath. Amiodarone, β-blocker.
  • Amiodarone + β-blocker (propranolol) — block sympathetic drive.
  • Sedation (deep sedation / intubation reduces adrenergic tone).
  • Fix K, Mg, ischemia, HF. Reprogram ICD. Call EP: urgent ablation, stellate ganglion block.
💊 Dose check

Typical adult doses. Procainamide: reduce in kidney disease (NAPA). Avoid procainamide with long QT or decompensated HF.

⚠️ Pitfalls

⌄
  • Giving verapamil/diltiazem for "SVT with aberrancy" → hemodynamic collapse.
  • Forgetting to check K and Mg.
  • Not asking: "Does this patient have an ICD?" → interrogate.
  • Missing ischemia as the cause of polymorphic VT.

🎓 Board corner

⌄
Stem Answer
Prior MI, stable WCT 170, BP 120/70 Monomorphic VT → procainamide/amiodarone
Same, BP 70/40, awake Synchronized cardioversion
Polymorphic VT, QTc 580 Magnesium sulfate IV
Polymorphic VT, normal QT, chest pain Ischemia → urgent cath
Secondary prevention after VT arrest (no reversible cause) ICD
EF ≤35% ≥40 d post-MI on GDMT, NYHA II–III Primary-prevention ICD

📚 References

⌄
  • Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Ventricular Arrhythmias and SCD. Circulation. 2018;138:e272.
  • Zeppenfeld K, et al. 2022 ESC Guidelines for VA and SCD. Eur Heart J. 2022;43:3997.
  • Ortiz M, et al. PROCAMIO. Eur Heart J. 2017;38:1329.
  • 2025 AHA Guidelines for CPR and ECC.
↩︎ Back to ❤️ Cardiology & EP